Read the article that inspired Professor Fisher: Nissen SE, Wolski K. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes. N Engl J Med. 2007. 356:2457-2471 http://www.nejm.org/doi/full/10.1056/nejmoa072761

 

For more from Professor Fisher, enrol on the EASD e-Learning course ‘SGLT-2 inhibitors’